Allergy and Asthma Proceedings

Papers
(The TQCC of Allergy and Asthma Proceedings is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Impact of steroids on the immune profiles of children with asthma living in the inner-city81
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist45
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination39
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children29
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis29
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks26
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being22
Future directions in allergen immunotherapy21
Venom allergen immunotherapy20
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis20
Operationalizing shared decision making in clinical practice19
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study18
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 202217
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii16
For the Patient15
For the Patient15
Evaluation and management of chronic cough in adults15
For the Patient15
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity13
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy13
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-1913
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes13
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis12
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course12
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps12
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics12
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy12
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome12
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department12
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma12
Diagnostic utility of basophil CD203c expression in β-lactam allergy11
Artificial intelligence and allergy: Shaping the future of diagnosis and therapy11
For the Patient11
For the Patient11
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment11
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs11
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?11
Treatment strategies for postviral olfactory dysfunction: A systematic review11
Effects of mechanical washing and drying on the removal of pet allergens10
A tribute to allergy and immunology fellowship training program directors and to the fellows they train10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination10
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy10
Navigating the management complexity in long-term asymptomatic immunodeficiency10
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii10
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible10
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities10
For the patient10
Guidelines for management of hereditary angioedema: What is new? What is missing?10
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii9
The long COVID syndrome: A conundrum for the allergist/immunologist9
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab9
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives9
Hematopoietic stem cell transplantation for primary immunodeficiency9
Metal implant allergy: A retrospective cohort analysis at a university allergy practice9
Evaluation of atopic diseases in patients with allergic contact dermatitis9
Benralizumab in the management of rare primary eosinophilic lung diseases9
Cost-effectiveness of school integrated pest management and air filtration in students with asthma8
Overview of secondary immunodeficiency8
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization8
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization8
Clinical features of anaphylaxis in children8
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema8
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-28
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study8
Primary Immunodeficiency: Specific antibody deficiency with normal IgG8
The association of timothy grass allergy and cat ownership on cat sensitization8
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber8
For the Patient7
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis7
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan7
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience7
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab7
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center7
Curcumin does not significantly affect immediate skin tests7
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH7
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis7
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis7
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers7
A masquerade of recurrent anaphylaxis6
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination6
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough6
Immunodeficiency: Burden of Illness6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study6
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis6
For the patient6
Peanut allergy in an adult following cardiac transplant from a non-atopic donor6
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience6
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida6
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic6
Assessing cross-reactivity in allergen immunotherapy6
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)6
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis6
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy6
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study6
0.17623090744019